Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c

August 6, 2012 12:56 PM EDT
Get Alerts ISIS Hot Sheet
Trade ISIS Now!
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment